[1]
2024. Preferential vasodilator effects of levosimendan in resistance pulmonary arteries in a rodent pulmonary embolism model. Global Cardiology. 2, 1 (Mar. 2024). DOI:https://doi.org/10.4081/cardio.2024.25.